Frequently Asked Questions
What are the purine levels in Cranberries Dried Sweetened?
While exact purine measurements for Cranberries Dried Sweetened are limited, it is classified as None for gout. This rating draws on established scientific consensus and typical values for its food group. Consult our full review for dietary recommendations.
Is Cranberries Dried Sweetened high in fructose?
Cranberries Dried Sweetened contains about 29.1g of fructose per 100g, which is considered high. Fructose is metabolized in the liver and increases uric acid production. This adds an additional gout risk beyond purine content alone. Limit consumption if you are prone to gout flares.
Should I avoid Cranberries Dried Sweetened with gout?
it is recommended to avoid Cranberries Dried Sweetened if you have gout due to its high fructose content. is high in fructose (29.1g/100g). Fructose accelerates purine breakdown in the liver, which raises uric acid levels independently of dietary purine intake. While its purine content may be low, the fructose risk alone makes it unsuitable for a strict gout diet.
What food category does Cranberries Dried Sweetened belong to?
Cranberries Dried Sweetened is classified under Sweets & Snacks in our gout food database. Knowing its food group helps you weigh it appropriately within your broader gout diet plan. Browse other sweets & snacks items to compare purine and fructose levels across similar foods.
What are gout-friendly alternatives to Cranberries Dried Sweetened?
Instead of Cranberries Dried Sweetened, consider choosing sweets & snacks options rated SAFE in our gout database — these have low purine (under 50 mg/100g) and low fructose (under 2g/100g). Browse our sweets & snacks category page to find the best substitutes for your gout diet plan.
Data Quality
This entry uses T2-level data:
At least one dimension is directly measured; the other is based on scientific consensus.
Sources include USDA FoodData Central (public domain, CC0 1.0), the USDA+ODS-NIH Database for the Purine Content of Foods Release 2.0 (2025), Kaneko et al. Biol Pharm Bull 2014, and ACR/EULAR clinical guidelines.